

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.82182374 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.82182374 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.60134844 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58957302 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.58957302 |
| 6 | peptide catabolic process (GO:0043171) | 4.39562064 |
| 7 | sequestering of metal ion (GO:0051238) | 4.24635237 |
| 8 | thyroid hormone generation (GO:0006590) | 4.17083076 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.16367764 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.16367764 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.16367764 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.16367764 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.16367764 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.16367764 |
| 15 | urate metabolic process (GO:0046415) | 4.13389869 |
| 16 | respiratory burst (GO:0045730) | 4.04545150 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03875527 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.96040470 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.89928038 |
| 20 | drug transmembrane transport (GO:0006855) | 3.89237255 |
| 21 | pentose-phosphate shunt (GO:0006098) | 3.87549438 |
| 22 | drug transport (GO:0015893) | 3.62008423 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60628536 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.60628536 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 3.57694111 |
| 26 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.52441167 |
| 27 | NADPH regeneration (GO:0006740) | 3.50702235 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.46854035 |
| 29 | toxin transport (GO:1901998) | 3.43960437 |
| 30 | glycoside metabolic process (GO:0016137) | 3.40202678 |
| 31 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.37319658 |
| 32 | response to peptidoglycan (GO:0032494) | 3.35592054 |
| 33 | negative regulation of interleukin-6 production (GO:0032715) | 3.34902488 |
| 34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.32961255 |
| 35 | reactive oxygen species biosynthetic process (GO:1903409) | 3.27122864 |
| 36 | signal peptide processing (GO:0006465) | 3.26326328 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.26265092 |
| 38 | response to fungus (GO:0009620) | 3.25694565 |
| 39 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.25270081 |
| 40 | cellular response to zinc ion (GO:0071294) | 3.24178323 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.23074265 |
| 42 | leukocyte aggregation (GO:0070486) | 3.21532843 |
| 43 | detection of other organism (GO:0098543) | 3.21386533 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19811432 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17806240 |
| 46 | neutrophil mediated immunity (GO:0002446) | 3.17327497 |
| 47 | thyroid hormone metabolic process (GO:0042403) | 3.17159074 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 3.15937293 |
| 49 | defense response to fungus (GO:0050832) | 3.09196788 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.08402165 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.08004139 |
| 52 | detection of bacterium (GO:0016045) | 3.06903369 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.04139189 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03462883 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.03191293 |
| 56 | detection of external biotic stimulus (GO:0098581) | 3.03071840 |
| 57 | protein retention in ER lumen (GO:0006621) | 3.00926354 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99005140 |
| 59 | tolerance induction (GO:0002507) | 2.97936412 |
| 60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97297062 |
| 61 | negative regulation of interleukin-8 production (GO:0032717) | 2.96697775 |
| 62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.96177435 |
| 63 | leukotriene metabolic process (GO:0006691) | 2.96116264 |
| 64 | neutrophil activation (GO:0042119) | 2.94483998 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93978980 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.93677594 |
| 67 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.91326914 |
| 68 | germinal center formation (GO:0002467) | 2.90112274 |
| 69 | mannose metabolic process (GO:0006013) | 2.90024363 |
| 70 | negative regulation of phagocytosis (GO:0050765) | 2.88571605 |
| 71 | negative regulation of interleukin-1 production (GO:0032692) | 2.88405330 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.87764685 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.84073001 |
| 74 | response to host immune response (GO:0052572) | 2.84073001 |
| 75 | axonemal dynein complex assembly (GO:0070286) | 2.83787050 |
| 76 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.83485490 |
| 77 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.83485490 |
| 78 | granulocyte activation (GO:0036230) | 2.81369409 |
| 79 | hydrogen peroxide catabolic process (GO:0042744) | 2.80876019 |
| 80 | amino sugar catabolic process (GO:0046348) | 2.80865602 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.80756904 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 2.80723684 |
| 83 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.80679570 |
| 84 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.80577393 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79312146 |
| 86 | lysine metabolic process (GO:0006553) | 2.79061331 |
| 87 | lysine catabolic process (GO:0006554) | 2.79061331 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78896733 |
| 89 | regulation of growth of symbiont in host (GO:0044126) | 2.78240696 |
| 90 | negative regulation of growth of symbiont in host (GO:0044130) | 2.78240696 |
| 91 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.78240696 |
| 92 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.78240696 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77866215 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76663497 |
| 95 | organic cation transport (GO:0015695) | 2.75644559 |
| 96 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.75606481 |
| 97 | glucose catabolic process (GO:0006007) | 2.75179069 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72139929 |
| 99 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.71077054 |
| 100 | cytidine metabolic process (GO:0046087) | 2.68521322 |
| 101 | cytidine catabolic process (GO:0006216) | 2.68521322 |
| 102 | cytidine deamination (GO:0009972) | 2.68521322 |
| 103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.65789453 |
| 104 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65407418 |
| 105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.64660714 |
| 106 | response to thyroid hormone (GO:0097066) | 2.63534004 |
| 107 | response to type I interferon (GO:0034340) | 2.63364934 |
| 108 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.62228831 |
| 109 | response to host (GO:0075136) | 2.60627613 |
| 110 | response to host defenses (GO:0052200) | 2.60627613 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60627613 |
| 112 | cellular response to exogenous dsRNA (GO:0071360) | 2.60235608 |
| 113 | leukocyte mediated cytotoxicity (GO:0001909) | 2.60105485 |
| 114 | leukotriene biosynthetic process (GO:0019370) | 2.59386259 |
| 115 | detection of biotic stimulus (GO:0009595) | 2.58980951 |
| 116 | angiogenesis involved in wound healing (GO:0060055) | 2.57115209 |
| 117 | amyloid precursor protein catabolic process (GO:0042987) | 2.56962071 |
| 118 | actin nucleation (GO:0045010) | 2.55564752 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.55129935 |
| 120 | leukocyte cell-cell adhesion (GO:0007159) | 2.55106293 |
| 121 | pinocytosis (GO:0006907) | 2.55076506 |
| 122 | regulation of mast cell activation (GO:0033003) | 2.54920228 |
| 123 | type I interferon signaling pathway (GO:0060337) | 2.53810116 |
| 124 | cellular response to type I interferon (GO:0071357) | 2.53810116 |
| 125 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52402309 |
| 126 | N-acetylneuraminate metabolic process (GO:0006054) | 2.51915159 |
| 127 | cellular response to vitamin D (GO:0071305) | 2.51526831 |
| 128 | motile cilium assembly (GO:0044458) | 2.51336825 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 2.51254131 |
| 130 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51088636 |
| 131 | apoptotic cell clearance (GO:0043277) | 2.50658785 |
| 132 | bone resorption (GO:0045453) | 2.50185450 |
| 133 | positive regulation of histone deacetylation (GO:0031065) | 2.49898453 |
| 134 | beta-amyloid metabolic process (GO:0050435) | 2.49746387 |
| 135 | cellular extravasation (GO:0045123) | 2.46831112 |
| 136 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46809757 |
| 137 | positive regulation of mast cell activation (GO:0033005) | 2.46410693 |
| 138 | regulation of regulated secretory pathway (GO:1903305) | 2.46224126 |
| 139 | negative regulation of innate immune response (GO:0045824) | 2.46204858 |
| 140 | lysosome organization (GO:0007040) | 2.46076302 |
| 141 | lytic vacuole organization (GO:0080171) | 2.46076302 |
| 142 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.45285284 |
| 143 | positive regulation of leukocyte degranulation (GO:0043302) | 2.45063761 |
| 144 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.44844254 |
| 145 | positive regulation of nuclease activity (GO:0032075) | 2.44536214 |
| 146 | macrophage activation (GO:0042116) | 2.43803604 |
| 147 | NADP metabolic process (GO:0006739) | 2.42489867 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.40930675 |
| 149 | negative regulation of bone resorption (GO:0045779) | 2.40688481 |
| 150 | positive regulation of lamellipodium assembly (GO:0010592) | 2.40321355 |
| 151 | regulation of tolerance induction (GO:0002643) | 2.39847259 |
| 152 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39187593 |
| 153 | positive regulation of B cell differentiation (GO:0045579) | 2.38820450 |
| 154 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38565723 |
| 155 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.38047893 |
| 156 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.37703384 |
| 157 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.37063804 |
| 158 | endosome to melanosome transport (GO:0035646) | 2.36167052 |
| 159 | endosome to pigment granule transport (GO:0043485) | 2.36167052 |
| 160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36089773 |
| 161 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.35188639 |
| 162 | positive regulation of mast cell degranulation (GO:0043306) | 2.33370144 |
| 163 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.33370144 |
| 164 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.32925991 |
| 165 | interferon-gamma secretion (GO:0072643) | 2.31611097 |
| 166 | regulation of interleukin-6 production (GO:0032675) | 2.31154169 |
| 167 | regulation of tumor necrosis factor production (GO:0032680) | 2.30616719 |
| 168 | defense response to protozoan (GO:0042832) | 2.29637608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.62416691 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.74651069 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.30563585 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06458431 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03763500 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.98155101 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73922349 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71199927 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.68123205 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67784472 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48809277 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42333676 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35638434 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35422229 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.27902275 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.25614551 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19675791 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18833944 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15454503 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14453769 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08733730 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.08109902 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05478055 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99431098 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99026371 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95474616 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92483840 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91209005 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89623460 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81809844 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81483963 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80485946 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.79570681 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79508440 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.77908936 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74784995 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74077290 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73923592 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70949181 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70895615 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.69925233 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68617792 |
| 43 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68094251 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67188848 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.66352548 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66167120 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66037553 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.63153451 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63004755 |
| 50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61813798 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.58547300 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.56507391 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53754491 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.48650357 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47201792 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46465202 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46439916 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46221747 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43784659 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42710188 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42021563 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40984571 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40019470 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37639530 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37126514 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36770115 |
| 67 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.36225846 |
| 68 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34902800 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34143659 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34126536 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34016291 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33953694 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.33884419 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32315786 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31569667 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30844513 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27336033 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27102210 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26171564 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25484531 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25104002 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24977029 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24654133 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22942341 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22442181 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22134852 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22094640 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21593105 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21072715 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20765235 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19141486 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19096969 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18813519 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17886626 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16935579 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16781863 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16404729 |
| 98 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.16219615 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14935716 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14610779 |
| 101 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13385006 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13345673 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13111095 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11894399 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11056397 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10729680 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10690598 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10674805 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10120979 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09686579 |
| 111 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08383818 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07754400 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06893355 |
| 114 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06575953 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03158861 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02544934 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00886258 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00823487 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00766341 |
| 120 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99778191 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99272935 |
| 122 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.99115123 |
| 123 | P300_27268052_Chip-Seq_Bcells_Human | 0.99034787 |
| 124 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98764823 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98706392 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.98291700 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98149900 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98010172 |
| 129 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97927493 |
| 130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97150283 |
| 131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96485466 |
| 132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95996631 |
| 133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94591768 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94439901 |
| 135 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93445136 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92054673 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92016974 |
| 138 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91919784 |
| 139 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90059107 |
| 140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89494594 |
| 141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89448078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.01749523 |
| 2 | MP0003436_decreased_susceptibility_to | 2.96612461 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.84588392 |
| 4 | MP0003303_peritoneal_inflammation | 2.70787063 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.62362178 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.59133685 |
| 7 | * MP0003172_abnormal_lysosome_physiology | 2.58172172 |
| 8 | MP0005360_urolithiasis | 2.40813133 |
| 9 | MP0006054_spinal_hemorrhage | 2.38870052 |
| 10 | MP0002419_abnormal_innate_immunity | 2.33037374 |
| 11 | MP0004043_abnormal_pH_regulation | 2.20415988 |
| 12 | MP0009785_altered_susceptibility_to | 2.17496490 |
| 13 | MP0008260_abnormal_autophagy | 2.15224653 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.07980244 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.06215455 |
| 16 | MP0005387_immune_system_phenotype | 2.02690940 |
| 17 | MP0001790_abnormal_immune_system | 2.02690940 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.01275705 |
| 19 | MP0000685_abnormal_immune_system | 2.00860343 |
| 20 | * MP0009643_abnormal_urine_homeostasis | 2.00705008 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.00700390 |
| 22 | MP0005025_abnormal_response_to | 1.93762072 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.84630111 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.83834295 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.80626271 |
| 26 | MP0009840_abnormal_foam_cell | 1.75790051 |
| 27 | MP0003279_aneurysm | 1.75047840 |
| 28 | MP0001800_abnormal_humoral_immune | 1.72094944 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.68948461 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.68788310 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.66409105 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.64140647 |
| 33 | MP0001819_abnormal_immune_cell | 1.64115209 |
| 34 | MP0002723_abnormal_immune_serum | 1.64114026 |
| 35 | MP0003195_calcinosis | 1.61874285 |
| 36 | MP0006082_CNS_inflammation | 1.59683238 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.58370831 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.58326254 |
| 39 | MP0005451_abnormal_body_composition | 1.57933398 |
| 40 | MP0003724_increased_susceptibility_to | 1.57092449 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.53389150 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52294936 |
| 43 | MP0005671_abnormal_response_to | 1.48562863 |
| 44 | MP0005083_abnormal_biliary_tract | 1.47959964 |
| 45 | MP0008469_abnormal_protein_level | 1.44374842 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.44314269 |
| 47 | MP0001849_ear_inflammation | 1.42030106 |
| 48 | MP0001958_emphysema | 1.41980414 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.39580109 |
| 50 | MP0001756_abnormal_urination | 1.39486058 |
| 51 | MP0005332_abnormal_amino_acid | 1.38968656 |
| 52 | MP0002405_respiratory_system_inflammati | 1.38707962 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.38085064 |
| 54 | MP0004947_skin_inflammation | 1.37859661 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.36255853 |
| 56 | MP0002254_reproductive_system_inflammat | 1.35385191 |
| 57 | MP0002132_abnormal_respiratory_system | 1.33084947 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.32333305 |
| 59 | MP0000858_altered_metastatic_potential | 1.32090104 |
| 60 | MP0004264_abnormal_extraembryonic_tissu | 1.30535441 |
| 61 | MP0005164_abnormal_response_to | 1.30507435 |
| 62 | MP0000716_abnormal_immune_system | 1.28569754 |
| 63 | MP0000343_altered_response_to | 1.28276301 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.27116648 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.27090971 |
| 66 | MP0005390_skeleton_phenotype | 1.26834406 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.26605459 |
| 68 | MP0005310_abnormal_salivary_gland | 1.26536394 |
| 69 | MP0002398_abnormal_bone_marrow | 1.26049552 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.25396020 |
| 71 | MP0003186_abnormal_redox_activity | 1.24154135 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.22431676 |
| 73 | MP0001542_abnormal_bone_strength | 1.21090824 |
| 74 | MP0000604_amyloidosis | 1.20618306 |
| 75 | MP0004883_abnormal_blood_vessel | 1.19533425 |
| 76 | MP0002429_abnormal_blood_cell | 1.17523150 |
| 77 | MP0000681_abnormal_thyroid_gland | 1.16655203 |
| 78 | MP0002722_abnormal_immune_system | 1.14668944 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.14484312 |
| 80 | MP0009278_abnormal_bone_marrow | 1.14312096 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.13414481 |
| 82 | MP0004381_abnormal_hair_follicle | 1.13172246 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 1.12998487 |
| 84 | MP0003091_abnormal_cell_migration | 1.12990164 |
| 85 | MP0003828_pulmonary_edema | 1.11184556 |
| 86 | MP0003075_altered_response_to | 1.10572746 |
| 87 | MP0010307_abnormal_tumor_latency | 1.07799847 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.07602309 |
| 89 | MP0000490_abnormal_crypts_of | 1.07297085 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 1.06181585 |
| 91 | MP0002933_joint_inflammation | 1.05016728 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.04831344 |
| 93 | MP0000015_abnormal_ear_pigmentation | 1.03439611 |
| 94 | MP0003448_altered_tumor_morphology | 1.03144690 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.02420009 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02109948 |
| 97 | MP0003795_abnormal_bone_structure | 1.01036852 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.98046603 |
| 99 | MP0003878_abnormal_ear_physiology | 0.98046603 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.97261028 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.96828967 |
| 102 | MP0003866_abnormal_defecation | 0.95696136 |
| 103 | MP0009764_decreased_sensitivity_to | 0.95425206 |
| 104 | MP0004858_abnormal_nervous_system | 0.94603194 |
| 105 | MP0004510_myositis | 0.93954214 |
| 106 | MP0000609_abnormal_liver_physiology | 0.91945764 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.89508462 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.89225893 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.89207897 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.89207897 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.88924960 |
| 112 | MP0005023_abnormal_wound_healing | 0.88839715 |
| 113 | MP0002135_abnormal_kidney_morphology | 0.88426143 |
| 114 | MP0003329_amyloid_beta_deposits | 0.87011099 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.86416726 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.85943867 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.84615404 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.83762812 |
| 119 | MP0000598_abnormal_liver_morphology | 0.82861947 |
| 120 | MP0002928_abnormal_bile_duct | 0.82519932 |
| 121 | MP0000371_diluted_coat_color | 0.82419016 |
| 122 | MP0010352_gastrointestinal_tract_polyps | 0.81908625 |
| 123 | MP0000249_abnormal_blood_vessel | 0.81344885 |
| 124 | MP0001853_heart_inflammation | 0.80985562 |
| 125 | MP0001663_abnormal_digestive_system | 0.80355945 |
| 126 | MP0009763_increased_sensitivity_to | 0.79153004 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.78937715 |
| 128 | MP0001873_stomach_inflammation | 0.78792742 |
| 129 | MP0005166_decreased_susceptibility_to | 0.78236133 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.77850400 |
| 131 | MP0002168_other_aberrant_phenotype | 0.76191107 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.76064617 |
| 133 | MP0004233_abnormal_muscle_weight | 0.72147187 |
| 134 | MP0005381_digestive/alimentary_phenotyp | 0.70881647 |
| 135 | MP0000470_abnormal_stomach_morphology | 0.69882070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.57252951 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.76078274 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.50529521 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.46429633 |
| 5 | * Urinary glycosaminoglycan excretion (HP:0003541) | 4.14883856 |
| 6 | * Mucopolysacchariduria (HP:0008155) | 4.14883856 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.07858865 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.94244217 |
| 9 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.84253318 |
| 10 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.84253318 |
| 11 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.84253318 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.69816429 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61230273 |
| 14 | Nasal polyposis (HP:0100582) | 3.60209971 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.48898750 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.45485517 |
| 17 | Orchitis (HP:0100796) | 3.44850225 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.14850386 |
| 19 | Stomatitis (HP:0010280) | 3.13816593 |
| 20 | Tetany (HP:0001281) | 3.09647615 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06635093 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06635093 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06635093 |
| 24 | IgM deficiency (HP:0002850) | 3.03492611 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 2.96815314 |
| 26 | Thin bony cortex (HP:0002753) | 2.94987784 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.94838838 |
| 28 | Optic neuritis (HP:0100653) | 2.94838838 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.92428516 |
| 30 | Abnormality of chloride homeostasis (HP:0011422) | 2.88687307 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.84487175 |
| 32 | Absent/shortened dynein arms (HP:0200106) | 2.84487175 |
| 33 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.81477926 |
| 34 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.81477926 |
| 35 | Gout (HP:0001997) | 2.80624561 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 2.80290825 |
| 37 | Joint stiffness (HP:0001387) | 2.79638338 |
| 38 | Thrombocytosis (HP:0001894) | 2.75623647 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.74219569 |
| 40 | Axonal loss (HP:0003447) | 2.71259535 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.63687636 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.59872386 |
| 43 | Peritonitis (HP:0002586) | 2.59028107 |
| 44 | J-shaped sella turcica (HP:0002680) | 2.56254482 |
| 45 | Gingivitis (HP:0000230) | 2.55341822 |
| 46 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.52563832 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52447844 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.52383185 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51909993 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51909993 |
| 51 | Increased circulating renin level (HP:0000848) | 2.49906066 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45465970 |
| 53 | Polyuria (HP:0000103) | 2.43542559 |
| 54 | Increased serum ferritin (HP:0003281) | 2.43541010 |
| 55 | Abnormal ciliary motility (HP:0012262) | 2.40701656 |
| 56 | Vertebral compression fractures (HP:0002953) | 2.36154122 |
| 57 | Recurrent skin infections (HP:0001581) | 2.34645120 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33597964 |
| 59 | Obstructive lung disease (HP:0006536) | 2.33597964 |
| 60 | Petechiae (HP:0000967) | 2.32047842 |
| 61 | Pustule (HP:0200039) | 2.29866700 |
| 62 | Myositis (HP:0100614) | 2.28388356 |
| 63 | Cellulitis (HP:0100658) | 2.27699028 |
| 64 | Abnormal urine output (HP:0012590) | 2.27423832 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.26259488 |
| 66 | Metabolic alkalosis (HP:0200114) | 2.24608979 |
| 67 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.24198481 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23092040 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.21792522 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 2.21792522 |
| 71 | Loss of speech (HP:0002371) | 2.20967401 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.20613636 |
| 73 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20517916 |
| 74 | Premature rupture of membranes (HP:0001788) | 2.19717939 |
| 75 | Abnormal platelet function (HP:0011869) | 2.19265217 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.19265217 |
| 77 | Abnormality of renal excretion (HP:0011036) | 2.18358700 |
| 78 | Long toe (HP:0010511) | 2.18194037 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.17004273 |
| 80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16961695 |
| 81 | Severe short stature (HP:0003510) | 2.16380743 |
| 82 | Osteomyelitis (HP:0002754) | 2.15142772 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.14762387 |
| 84 | Recurrent viral infections (HP:0004429) | 2.13684907 |
| 85 | Periodontitis (HP:0000704) | 2.13230729 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.12735611 |
| 87 | Ketoacidosis (HP:0001993) | 2.08871629 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08251325 |
| 89 | Spondylolisthesis (HP:0003302) | 2.08048767 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.07219878 |
| 91 | Hypomagnesemia (HP:0002917) | 2.04000965 |
| 92 | Hemoptysis (HP:0002105) | 2.02875291 |
| 93 | Hyperuricemia (HP:0002149) | 2.01873729 |
| 94 | Increased purine levels (HP:0004368) | 2.01873729 |
| 95 | Metaphyseal cupping (HP:0003021) | 2.01375886 |
| 96 | Pathologic fracture (HP:0002756) | 2.00991064 |
| 97 | Tetraparesis (HP:0002273) | 1.98452975 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.98446838 |
| 99 | Distal upper limb amyotrophy (HP:0007149) | 1.97449601 |
| 100 | Upper limb amyotrophy (HP:0009129) | 1.97449601 |
| 101 | Broad face (HP:0000283) | 1.97311718 |
| 102 | Abnormality of magnesium homeostasis (HP:0004921) | 1.96913265 |
| 103 | Cheilitis (HP:0100825) | 1.96535070 |
| 104 | Hypophosphatemia (HP:0002148) | 1.96476586 |
| 105 | Hand muscle atrophy (HP:0009130) | 1.95765382 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.95553101 |
| 107 | Urticaria (HP:0001025) | 1.94438310 |
| 108 | Protrusio acetabuli (HP:0003179) | 1.94149672 |
| 109 | Chronic otitis media (HP:0000389) | 1.93765373 |
| 110 | Hyperaldosteronism (HP:0000859) | 1.93380437 |
| 111 | Renal salt wasting (HP:0000127) | 1.92666489 |
| 112 | Late onset (HP:0003584) | 1.92097117 |
| 113 | Abnormal drinking behavior (HP:0030082) | 1.91431153 |
| 114 | Polydipsia (HP:0001959) | 1.91431153 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90923997 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.89971656 |
| 117 | Persistence of primary teeth (HP:0006335) | 1.89776263 |
| 118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89450071 |
| 119 | Thoracic kyphosis (HP:0002942) | 1.89325850 |
| 120 | Meningitis (HP:0001287) | 1.89278589 |
| 121 | Alkalosis (HP:0001948) | 1.88094059 |
| 122 | Amyloidosis (HP:0011034) | 1.86790077 |
| 123 | Stridor (HP:0010307) | 1.85836004 |
| 124 | Elevated alkaline phosphatase (HP:0003155) | 1.84125821 |
| 125 | Joint hemorrhage (HP:0005261) | 1.81214271 |
| 126 | Inflammation of the large intestine (HP:0002037) | 1.81110322 |
| 127 | Episodic fever (HP:0001954) | 1.80967202 |
| 128 | Goiter (HP:0000853) | 1.80861345 |
| 129 | Cardiomegaly (HP:0001640) | 1.80463657 |
| 130 | Beaking of vertebral bodies (HP:0004568) | 1.80399628 |
| 131 | Absent frontal sinuses (HP:0002688) | 1.79871592 |
| 132 | Hypochromic anemia (HP:0001931) | 1.79791640 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.78403837 |
| 134 | Nausea (HP:0002018) | 1.78332802 |
| 135 | Hypokalemia (HP:0002900) | 1.77288920 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.77172251 |
| 137 | Vasculitis (HP:0002633) | 1.76972526 |
| 138 | Global brain atrophy (HP:0002283) | 1.76519364 |
| 139 | Hypoglycemic coma (HP:0001325) | 1.76039191 |
| 140 | Genu recurvatum (HP:0002816) | 1.75698130 |
| 141 | Easy fatigability (HP:0003388) | 1.75180917 |
| 142 | Pulmonary infiltrates (HP:0002113) | 1.74737772 |
| 143 | Hyperphosphatemia (HP:0002905) | 1.73429334 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72736562 |
| 145 | Abnormality of the thoracic spine (HP:0100711) | 1.72498482 |
| 146 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.72486169 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.72445529 |
| 148 | Deformed sella turcica (HP:0002681) | 1.69875340 |
| 149 | Abnormality of the pericardium (HP:0001697) | 1.69644204 |
| 150 | Encephalitis (HP:0002383) | 1.68928107 |
| 151 | Short nail (HP:0001799) | 1.68675388 |
| 152 | Increased IgE level (HP:0003212) | 1.67477722 |
| 153 | Emphysema (HP:0002097) | 1.67259459 |
| 154 | Keratoconjunctivitis (HP:0001096) | 1.65630790 |
| 155 | Anorexia (HP:0002039) | 1.65339262 |
| 156 | Rhinitis (HP:0012384) | 1.65182304 |
| 157 | Purpura (HP:0000979) | 1.65047729 |
| 158 | Nuclear cataract (HP:0100018) | 1.64620506 |
| 159 | Bronchiectasis (HP:0002110) | 1.63757448 |
| 160 | Testicular atrophy (HP:0000029) | 1.63716627 |
| 161 | Mesangial abnormality (HP:0001966) | 1.62595209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.44093031 |
| 2 | TRIB3 | 3.43254719 |
| 3 | IRAK4 | 2.91229232 |
| 4 | MAP4K1 | 2.78982049 |
| 5 | BLK | 2.48023438 |
| 6 | MAPK15 | 2.36863384 |
| 7 | PKN2 | 2.27113619 |
| 8 | TYK2 | 2.24601831 |
| 9 | KIT | 2.14581737 |
| 10 | TBK1 | 2.12742717 |
| 11 | IRAK3 | 2.06841584 |
| 12 | TAOK3 | 2.06810263 |
| 13 | WNK4 | 1.93947366 |
| 14 | MAP3K11 | 1.90896124 |
| 15 | LRRK2 | 1.87003157 |
| 16 | EPHB1 | 1.78689331 |
| 17 | BTK | 1.77676216 |
| 18 | ZAP70 | 1.76083040 |
| 19 | STK10 | 1.74209679 |
| 20 | PRKD2 | 1.73199141 |
| 21 | MAP3K14 | 1.71344093 |
| 22 | RIPK4 | 1.68101204 |
| 23 | SCYL2 | 1.67688188 |
| 24 | NME2 | 1.67119972 |
| 25 | GRK6 | 1.63109604 |
| 26 | CDC42BPA | 1.60496357 |
| 27 | RPS6KA4 | 1.58976385 |
| 28 | WNK3 | 1.58418751 |
| 29 | JAK3 | 1.56342296 |
| 30 | MAP2K3 | 1.55763280 |
| 31 | MAP3K10 | 1.54711767 |
| 32 | JAK1 | 1.52965815 |
| 33 | TNK2 | 1.51233022 |
| 34 | SIK3 | 1.49677101 |
| 35 | PTK6 | 1.42080962 |
| 36 | PAK4 | 1.41502956 |
| 37 | EPHA2 | 1.40860973 |
| 38 | FLT3 | 1.40027493 |
| 39 | TAOK1 | 1.39349020 |
| 40 | SYK | 1.31653528 |
| 41 | FGFR4 | 1.30666463 |
| 42 | PRPF4B | 1.28517977 |
| 43 | EEF2K | 1.26293384 |
| 44 | CSK | 1.24092994 |
| 45 | TEC | 1.23920404 |
| 46 | TGFBR2 | 1.17704390 |
| 47 | SIK2 | 1.15097894 |
| 48 | PASK | 1.14691974 |
| 49 | TTN | 1.14430051 |
| 50 | TESK1 | 1.13876935 |
| 51 | ICK | 1.13764357 |
| 52 | TAOK2 | 1.13074865 |
| 53 | HCK | 1.11825160 |
| 54 | MARK2 | 1.10400041 |
| 55 | STK38 | 1.07246853 |
| 56 | RIPK1 | 1.06883296 |
| 57 | MAP3K6 | 1.06352229 |
| 58 | IKBKE | 1.06137371 |
| 59 | ITK | 1.04807014 |
| 60 | MAPKAPK3 | 1.04732971 |
| 61 | NEK9 | 1.04581965 |
| 62 | CSF1R | 1.03241401 |
| 63 | BCKDK | 1.00761936 |
| 64 | FES | 0.96123953 |
| 65 | MST4 | 0.95111239 |
| 66 | SMG1 | 0.93449844 |
| 67 | PIM1 | 0.92834632 |
| 68 | TRPM7 | 0.88894610 |
| 69 | PIM2 | 0.87718504 |
| 70 | PTK2B | 0.87449555 |
| 71 | JAK2 | 0.86481238 |
| 72 | LYN | 0.86106708 |
| 73 | GRK7 | 0.85637699 |
| 74 | ADRBK2 | 0.84052130 |
| 75 | MST1R | 0.83822659 |
| 76 | MAP3K3 | 0.82019410 |
| 77 | LCK | 0.81133848 |
| 78 | MAP3K7 | 0.80783926 |
| 79 | HIPK2 | 0.75440950 |
| 80 | KDR | 0.74890495 |
| 81 | EIF2AK3 | 0.74268794 |
| 82 | MUSK | 0.74033292 |
| 83 | MAP3K8 | 0.73285560 |
| 84 | MAP2K6 | 0.72295768 |
| 85 | NEK2 | 0.72080483 |
| 86 | ACVR1B | 0.70486345 |
| 87 | FGR | 0.70377895 |
| 88 | IKBKB | 0.68179689 |
| 89 | FRK | 0.65878575 |
| 90 | EPHA3 | 0.65833476 |
| 91 | IRAK1 | 0.65698604 |
| 92 | MATK | 0.65197392 |
| 93 | PTK2 | 0.64603672 |
| 94 | RPS6KA2 | 0.64322553 |
| 95 | TESK2 | 0.63768339 |
| 96 | RPS6KA6 | 0.63094759 |
| 97 | DYRK1B | 0.62306807 |
| 98 | CLK1 | 0.62294078 |
| 99 | RPS6KL1 | 0.60874070 |
| 100 | RPS6KC1 | 0.60874070 |
| 101 | MAPK11 | 0.60853338 |
| 102 | BMX | 0.59233264 |
| 103 | PDPK1 | 0.58903488 |
| 104 | TGFBR1 | 0.58450223 |
| 105 | SIK1 | 0.57616863 |
| 106 | PRKCD | 0.57520901 |
| 107 | PIK3CG | 0.57314426 |
| 108 | LIMK1 | 0.57225417 |
| 109 | IRAK2 | 0.56316653 |
| 110 | PDK1 | 0.53807684 |
| 111 | ADRBK1 | 0.52827399 |
| 112 | MAP3K13 | 0.52096291 |
| 113 | MAPK7 | 0.51133611 |
| 114 | NEK1 | 0.50538288 |
| 115 | MARK3 | 0.50326349 |
| 116 | PRKCH | 0.50004820 |
| 117 | TXK | 0.49950166 |
| 118 | STK4 | 0.49434453 |
| 119 | CDK12 | 0.48688015 |
| 120 | ABL2 | 0.48437991 |
| 121 | MAP2K2 | 0.47615691 |
| 122 | DDR2 | 0.47038092 |
| 123 | CAMKK1 | 0.45968689 |
| 124 | CHUK | 0.44118610 |
| 125 | PRKD1 | 0.42963525 |
| 126 | KSR2 | 0.40947636 |
| 127 | PRKG2 | 0.37246097 |
| 128 | MAP3K1 | 0.37230241 |
| 129 | EGFR | 0.35994830 |
| 130 | MTOR | 0.35324952 |
| 131 | ALK | 0.34565586 |
| 132 | CAMK1D | 0.34134975 |
| 133 | ABL1 | 0.33110564 |
| 134 | MAPKAPK2 | 0.31174989 |
| 135 | ERBB3 | 0.30789527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.93816290 |
| 2 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.45665370 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 3.25013973 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37958629 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16530395 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13846890 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88095854 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80145732 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.79153192 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73626743 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73135901 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72895536 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.58848561 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56793472 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.52825879 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.52764763 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.51132190 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51065413 |
| 19 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.50271260 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40875379 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.32634919 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.32606398 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32349919 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.32267326 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.32235057 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30762976 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27232859 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27059690 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22458087 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22002000 |
| 31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20986617 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19082529 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18825523 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.15884456 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.14926786 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14168160 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.12600788 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12486019 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11828676 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08403468 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.06740109 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.05935824 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03864942 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02322747 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01765907 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01145145 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01106957 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00280153 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.99815899 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98721625 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98252957 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97397636 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96777689 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.93993993 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93851253 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92255253 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92202161 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.92196638 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.91439143 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91170574 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90909687 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89522081 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89419946 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87739265 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85742964 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.85579995 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85136437 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 0.83927160 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82895738 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81764598 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.79563925 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.79254722 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79209629 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78739023 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78425974 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78364493 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76707044 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76337880 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74721506 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73827572 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73400980 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.72663136 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72321713 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72157706 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71265956 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.70962539 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70516078 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70435210 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70427873 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69866246 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.69781183 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69393458 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68978558 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66414061 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.65832310 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64962489 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64407339 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64232926 |
| 99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63131784 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62980498 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62676162 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62639700 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62469858 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61918828 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60786921 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57775980 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57060924 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55846697 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55789838 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.54579366 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.53381662 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53255305 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53115397 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.51363946 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.51192540 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50321034 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49254257 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48737853 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48683258 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48622912 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48616748 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47265244 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46226154 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45783943 |
| 125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45177348 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42725454 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42166336 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41922142 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40802247 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40703978 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40123253 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39995518 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.39776708 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39405751 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39402090 |
| 136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39061556 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37725677 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37618915 |

